Jump to section
To combine the power of behavioral science with artificial intelligence to drive positive behavior change for the betterment of all people.
Many candidates hear
back within 2 weeks
Many healthcare systems struggle to engage patients effectively. Traditional methods often fail to account for the individual barriers and motivational factors that influence health behaviors, leading to suboptimal patient engagement and poor health outcomes.
To tackle this, Lirio has developed a platform that combines behavioral science with artificial intelligence. Its Large Behavioral Model (LBM) predicts the next health-related action for an individual, enabling hyper-personalized interventions. Using techniques like "pros and cons awareness", Lirio's Precision Nudging™ helps patients overcome specific barriers to healthcare, driving meaningful behavior change.
Liro's approach has proven successful, significantly improving patient engagement and healthcare outcomes. Its intervention led over 60% of disengaged diabetic patients to attend primary care visits, far exceeding targets. With strong endorsements and significant funding, the company is poised to expand its reach and enhance healthcare delivery by fostering sustained, positive behavior changes in patients globally.
Kirsty
Company Specialist at Welcome to the Jungle
Jan 2024
$3.2m
LATE VC
Dec 2016
$1m
SEED
Marten den Haring
(CEO (not founder))Joined Lirio in 2019 as the COO and Chief Product Officer and was promoted to CEO in 2021. Prior to this, they worked as an SVP at Element AI, as a Chief Product Officer at Digital Reasoning, and as a VP and GM at OpenText.